Ledipasvir/sofosbuvir in chronic hepatitis C: a guide to its use in the EU Gillian M. Keating Adis Drug Q&A 05 August 2015 Pages: 289 - 295
CT-P13 (an infliximab biosimilar): a guide to its use in the EU Kate McKeage Adis Drug Q&A 07 August 2015 Pages: 296 - 301
Manage chronic pruritus in the elderly with various agents depending on the pathophysiology and aetiology of the condition Adis Medical Writers Disease Management 13 June 2015 Pages: 302 - 306
Consider dosing, monitoring and complications when using anticoagulants to treat acute venous thromboembolism in paediatric patients Adis Medical Writers Disease Management 01 July 2015 Pages: 307 - 310
First reports of adverse drug reactions in recent weeks Drug Reactions and Interactions 19 August 2015 Pages: 311 - 312
Vital to monitor, prevent and treat metabolic and cardiovascular adverse events induced by long-term systemic glucocorticoid therapy Adis Medical Writers Drug Reactions and Interactions 09 June 2015 Pages: 313 - 315
Community pharmacists’ attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: a mixed methods study Maria DuartePaula FerreiraAna Paula Martins Original Research Article 11 July 2015 Pages: 316 - 322
